These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 38273271)

  • 1. Estimating the global prevalence of chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis.
    Al Wachami N; Guennouni M; Iderdar Y; Boumendil K; Arraji M; Mourajid Y; Bouchachi FZ; Barkaoui M; Louerdi ML; Hilali A; Chahboune M
    BMC Public Health; 2024 Jan; 24(1):297. PubMed ID: 38273271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating prevalence of chronic obstructive pulmonary disease in the Southern Cone of Latin America: how different spirometric criteria may affect disease burden and health policies.
    Sobrino E; Irazola VE; Gutierrez L; Chen CS; Lanas F; Calandrelli M; Ponzo J; Mores N; Serón P; Lee A; He J; Rubinstein AL
    BMC Pulm Med; 2017 Dec; 17(1):187. PubMed ID: 29228947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of patients newly diagnosed with COPD by the fixed ratio and lower limit of normal criteria: a cross-sectional analysis of the TargetCOPD trial.
    Miller MR; Haroon S; Jordan RE; Sitch AJ; Dickens AP; Enocson A; Fitzmaurice DA; Adab P
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1979-1986. PubMed ID: 29950827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of comorbidities and prognosis in patients with COPD diagnosed with the fixed ratio and the lower limit of normal: a systematic review and meta-analysis.
    Xiong H; Huang Q; Shuai T; Zhu L; Zhang C; Zhang M; Wang Y; Liu J
    Respir Res; 2020 Jul; 21(1):189. PubMed ID: 32677946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COPD in chronic heart failure: less common than previously thought?
    Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF
    Heart Lung; 2013; 42(5):365-71. PubMed ID: 23998385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the prevalence of chronic obstructive pulmonary disease diagnosed by lower limit of normal and fixed ratio criteria.
    Hwang YI; Kim CH; Kang HR; Shin T; Park SM; Jang SH; Park YB; Kim CH; Kim DG; Lee MG; Hyun IG; Jung KS
    J Korean Med Sci; 2009 Aug; 24(4):621-6. PubMed ID: 19654942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis.
    Adeloye D; Song P; Zhu Y; Campbell H; Sheikh A; Rudan I;
    Lancet Respir Med; 2022 May; 10(5):447-458. PubMed ID: 35279265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global and regional estimates of COPD prevalence: Systematic review and meta-analysis.
    Adeloye D; Chua S; Lee C; Basquill C; Papana A; Theodoratou E; Nair H; Gasevic D; Sridhar D; Campbell H; Chan KY; Sheikh A; Rudan I;
    J Glob Health; 2015 Dec; 5(2):020415. PubMed ID: 26755942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spirometry for the diagnosis of airway obstruction in patients with risk factors for COPD: the GOLD and lower limit of normal criteria.
    Grafino M; Todo-Bom F; Lutas AC; Cabral J; Pereira M; Valença J; Furtado ST
    J Bras Pneumol; 2022; 47(6):e20210124. PubMed ID: 35019054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex, susceptibility to smoking and chronic obstructive pulmonary disease: the effect of different diagnostic criteria. Analysis of the Health Survey for England.
    Jordan RE; Miller MR; Lam KB; Cheng KK; Marsh J; Adab P
    Thorax; 2012 Jul; 67(7):600-5. PubMed ID: 22382600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of obstructive lung disease in an African country using definitions from different international guidelines: a community based cross-sectional survey.
    Pefura-Yone EW; Kengne AP; Balkissou AD; Magne-Fotso CG; Ngo-Yonga M; Boulleys-Nana JR; Efe-de-Melingui NR; Ndjeutcheu-Moualeu PI; Mbele-Onana CL; Kenmegne-Noumsi EC; Kolontchang-Yomi BL; Theubo-Kamgang BJ; Ebouki ER; Djuikam-Kamga CK; Amougou F; Mboumtou L; Petchou-Talla EL; Kuaban C;
    BMC Res Notes; 2016 Feb; 9():124. PubMed ID: 26917543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung function, forced expiratory volume in 1 s decline and COPD hospitalisations over 44 years of follow-up.
    Zaigham S; Wollmer P; Engström G
    Eur Respir J; 2016 Mar; 47(3):742-50. PubMed ID: 26647443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of Chronic Obstructive Pulmonary Disease and its Associated Factors in Nepal: Findings from a Community-based Household Survey.
    Adhikari TB; Acharya P; Högman M; Neupane D; Karki A; Drews A; Cooper BG; Sigsgaard T; Kallestrup P
    Int J Chron Obstruct Pulmon Dis; 2020; 15():2319-2331. PubMed ID: 33061350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.
    Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prevalence of Chronic Obstructive Pulmonary Disease (COPD) and the Heterogeneity of Risk Factors in the Canadian Population: Results from the Canadian Obstructive Lung Disease (COLD) Study.
    Leung C; Bourbeau J; Sin DD; Aaron SD; FitzGerald JM; Maltais F; Marciniuk DD; O'Donnell D; Hernandez P; Chapman KR; Walker B; Road JD; Zheng L; Zou C; Hogg JC; Tan WC;
    Int J Chron Obstruct Pulmon Dis; 2021; 16():305-320. PubMed ID: 33603357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating population prevalence of potential airflow obstruction using different spirometric criteria: a pooled cross-sectional analysis of persons aged 40-95 years in England and Wales.
    Scholes S; Moody A; Mindell JS
    BMJ Open; 2014 Jul; 4(7):e005685. PubMed ID: 25056983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: a BOLD study.
    Al Ghobain M; Alhamad EH; Alorainy HS; Al Kassimi F; Lababidi H; Al-Hajjaj MS
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1252-7. PubMed ID: 26459542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profile and preliminary results of Iranian sub cohort chronic obstructive pulmonary disease (COPD) in Shahrekord PERSIAN cohort in southwest Iran.
    Kiani FZ; Ahmadi A; Babadi AS; Rouhi H
    BMC Pulm Med; 2021 Mar; 21(1):105. PubMed ID: 33765987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed ratio or lower limit of normal for the FEV
    Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U
    Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.